glp-1 receptor agonist after roux-en-y gastric bypass Post metabolic bariatric surgery weight regain: the importance of levels Obesity Treatment With Bariatric Surgery

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

Novo-Nordisk A/S, Eli Lilly And Company, Sanofi, AstraZeneca, Pfizer Inc., Amgen, Inc., and Innovent Biologics, Inc

Discover the research, how they work, who should try these, and more.

Mounjaro and Ozempic both help control blood sugar and promote weight loss in people with diabetes

Berberine is not a GLP-1 agonist, though both compounds influence metabolic pathways